These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
128 related items for PubMed ID: 12891629
1. Polymorphisms of estrogen receptor alpha in prostate cancer. Tanaka Y, Sasaki M, Kaneuchi M, Shiina H, Igawa M, Dahiya R. Mol Carcinog; 2003 Aug; 37(4):202-8. PubMed ID: 12891629 [Abstract] [Full Text] [Related]
2. Catechol-O-methyltransferase gene polymorphisms in benign prostatic hyperplasia and sporadic prostate cancer. Tanaka Y, Sasaki M, Shiina H, Tokizane T, Deguchi M, Hirata H, Hinoda Y, Okayama N, Suehiro Y, Urakami S, Kawakami T, Kaneuchi M, Pookot D, Igawa M, Okuyama A, Ishii N, Dahiya R. Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):238-44. PubMed ID: 16492910 [Abstract] [Full Text] [Related]
3. Genetic polymorphisms of estrogen receptor alpha, CYP19, catechol-O-methyltransferase are associated with familial prostate carcinoma risk in a Japanese population. Suzuki K, Nakazato H, Matsui H, Koike H, Okugi H, Kashiwagi B, Nishii M, Ohtake N, Nakata S, Ito K, Yamanaka H. Cancer; 2003 Oct 01; 98(7):1411-6. PubMed ID: 14508827 [Abstract] [Full Text] [Related]
4. Allelic variants of aromatase and the androgen and estrogen receptors: toward a multigenic model of prostate cancer risk. Modugno F, Weissfeld JL, Trump DL, Zmuda JM, Shea P, Cauley JA, Ferrell RE. Clin Cancer Res; 2001 Oct 01; 7(10):3092-6. PubMed ID: 11595700 [Abstract] [Full Text] [Related]
5. Genetic polymorphisms of hormone-related genes and prostate cancer risk in the Japanese population. Fukatsu T, Hirokawa Y, Araki T, Hioki T, Murata T, Suzuki H, Ichikawa T, Tsukino H, Qiu D, Katoh T, Sugimura Y, Yatani R, Shiraishi T, Watanabe M. Anticancer Res; 2004 Oct 01; 24(4):2431-7. PubMed ID: 15330195 [Abstract] [Full Text] [Related]
6. Estrogen receptor codon 594 and HER2 codon 655 polymorphisms and breast cancer risk. Akisik E, Dalay N. Exp Mol Pathol; 2004 Jun 01; 76(3):260-3. PubMed ID: 15126109 [Abstract] [Full Text] [Related]
7. Cytokine gene polymorphisms as potential risk and protective factors in renal cell carcinoma. Baştürk B, Yavaşçaoğlu I, Vuruşkan H, Göral G, Oktay B, Oral HB. Cytokine; 2005 Apr 07; 30(1):41-5. PubMed ID: 15784411 [Abstract] [Full Text] [Related]
8. Association of V89L SRD5A2 polymorphism with prostate cancer development in a Japanese population. Li Z, Habuchi T, Mitsumori K, Kamoto T, Kinoshitu H, Segawa T, Ogawa O, Kato T. J Urol; 2003 Jun 07; 169(6):2378-81. PubMed ID: 12771801 [Abstract] [Full Text] [Related]
9. Joint effects of the CYP1A1 MspI, ERalpha PvuII, and ERalpha XbaI polymorphisms on the risk of breast cancer: results from a population-based case-control study in Shanghai, China. Shen Y, Li DK, Wu J, Zhang Z, Gao E. Cancer Epidemiol Biomarkers Prev; 2006 Feb 07; 15(2):342-7. PubMed ID: 16492926 [Abstract] [Full Text] [Related]
10. p53 Codon 72 and p21 codon 31 polymorphisms in prostate cancer. Huang SP, Wu WJ, Chang WS, Wu MT, Chen YY, Chen YJ, Yu CC, Wu TT, Lee YH, Huang JK, Huang CH. Cancer Epidemiol Biomarkers Prev; 2004 Dec 07; 13(12):2217-24. PubMed ID: 15598783 [Abstract] [Full Text] [Related]
11. Polymorphisms of estrogen receptor alpha gene in endometrial cancer. Sasaki M, Tanaka Y, Kaneuchi M, Sakuragi N, Dahiya R. Biochem Biophys Res Commun; 2002 Sep 27; 297(3):558-64. PubMed ID: 12270131 [Abstract] [Full Text] [Related]
12. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women. Singh V, Rastogi N, Sinha A, Kumar A, Mathur N, Singh MP. Breast Cancer Res Treat; 2007 Jan 27; 101(1):73-81. PubMed ID: 16807674 [Abstract] [Full Text] [Related]
13. Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk. Sun J, Wiklund F, Zheng SL, Chang B, Bälter K, Li L, Johansson JE, Li G, Adami HO, Liu W, Tolin A, Turner AR, Meyers DA, Isaacs WB, Xu J, Grönberg H. J Natl Cancer Inst; 2005 Apr 06; 97(7):525-32. PubMed ID: 15812078 [Abstract] [Full Text] [Related]
14. Association of estrogen receptor 1 intron 1 C/T polymorphism in Korean vitiligo patients. Jin SY, Park HH, Li GZ, Lee HJ, Hong MS, Park HJ, Park HK, Seo JC, Yim SV, Chung JH, Lee MH. J Dermatol Sci; 2004 Sep 06; 35(3):181-6. PubMed ID: 15381239 [Abstract] [Full Text] [Related]
15. Quantitative RT-PCR analysis of estrogen receptor gene expression in laser microdissected prostate cancer tissue. Walton TJ, Li G, McCulloch TA, Seth R, Powe DG, Bishop MC, Rees RC. Prostate; 2009 Jun 01; 69(8):810-9. PubMed ID: 19189301 [Abstract] [Full Text] [Related]
16. Association of XPD polymorphisms with prostate cancer in Taiwanese patients. Bau DT, Wu HC, Chiu CF, Lin CC, Hsu CM, Wang CL, Wang RF, Tsai FJ. Anticancer Res; 2007 Jun 01; 27(4C):2893-6. PubMed ID: 17695467 [Abstract] [Full Text] [Related]
17. Polymorphisms in tumor necrosis factor-A gene and prostate cancer risk in North Indian cohort. Kesarwani P, Mandhani A, Mittal RD. J Urol; 2009 Dec 01; 182(6):2938-43. PubMed ID: 19846139 [Abstract] [Full Text] [Related]
18. Estrogen receptor beta polymorphism is associated with prostate cancer risk. Thellenberg-Karlsson C, Lindström S, Malmer B, Wiklund F, Augustsson-Bälter K, Adami HO, Stattin P, Nilsson M, Dahlman-Wright K, Gustafsson JA, Grönberg H. Clin Cancer Res; 2006 Mar 15; 12(6):1936-41. PubMed ID: 16551880 [Abstract] [Full Text] [Related]
19. Estrogen receptor alpha-351 XbaI*G and -397 PvuII*C-related genotypes and alleles are associated with higher susceptibilities of endometriosis and leiomyoma. Hsieh YY, Wang YK, Chang CC, Lin CS. Mol Hum Reprod; 2007 Feb 15; 13(2):117-22. PubMed ID: 17121748 [Abstract] [Full Text] [Related]
20. Polymorphisms of human estrogen receptor (ER) gene alpha and beta in prostate cancer PC-EW and PC-OR cell lines. Bergner CC, Krause FS, Zugor V, Rith T, Schrott KM, Endele S, Engehausen DG. Anticancer Res; 2007 Feb 15; 27(4A):2071-4. PubMed ID: 17649823 [Abstract] [Full Text] [Related] Page: [Next] [New Search]